未登录

S

Sandra E. Reznik

montefiore medical center

H指数:24

被引数:1,780

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

UB-221, an antibody that neutralizes IgE and downregulates the CD23 receptor: a potential treatment for the alpha-gal syndrome

UB-221，一种中和IgE并下调CD23受体的抗体：一种α-半乳糖综合征的潜在治疗方法

Ticks and Tick-borne Diseases

IF3.4

2025-10-290

OAAI

HJP 272, an endothelin receptor antagonist, and its role in cancer cell migration and invasion

HJP 272，一种内皮素受体拮抗剂，及其在癌细胞迁移和侵袭中的作用

Translational Oncology

IF4.1

2025-08-050

PRE

Improving the safety of N,N-dimethylacetamide (DMA) as a potential treatment for preterm birth in a pregnant mouse model using a vaginal nanoformulation

通过阴道纳米制剂改善N,N-二甲基乙酰胺（DMA）作为早产潜在治疗药物在孕鼠模型中的安全性

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

IF4.2

2025-06-010

OAAI

N,N-dimethylacetamide blocks inflammation-induced preterm birth and remediates maternal systemic immune responses

SCIENTIFIC REPORTS

IF3.9

2025-03-100

OAAI

Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase

MOLECULAR AND CELLULAR ENDOCRINOLOGY

IF3.6

2025-01-010

PRE

Human cord plasma proteomic analysis reveals sexually dimorphic proteins associated with intrauterine growth restriction

IF3.9

2023-12-071

OAAI

The relationship between elastin cross linking and alveolar wall rupture in human pulmonary emphysema

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

IF3.5

2023-06-016

PRE

N,N-dimethylacetamide targets neuroinflammation in Alzheimer's disease in in-vitro and ex-vivo models

SCIENTIFIC REPORTS

IF3.9

2023-05-013

OAAI

Vaginal Nanoformulations for the Management of Preterm Birth

用于早产管理的阴道纳米制剂

IF5.5

2022-09-234

OAAI

N, N-Dimethylacetamide (DMA) improves survival in a lipopolysaccharide (LPS)-induced endotoxemia model

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

PRE

Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES

IF3.4

2022-02-124

OAAI

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms

胰岛素抵抗通过多种机制加剧阿尔茨海默病

FRONTIERS IN NEUROSCIENCE

IF3.2

2021-07-1955

OAAI

Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma

IF5.5

2021-07-0136

OAAI

Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2021-03-0116

OAAI

Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?

PHARMACOLOGICAL RESEARCH

IF10.5

2020-10-014

OAAI

Antioxidant Effects of N-Acetylcysteine Prevent Programmed Metabolic Disease in Mice

IF7.5

2020-05-2224

OA

Revisiting mTOR inhibitors as anticancer agents

DRUG DISCOVERY TODAY

IF7.5

2019-10-0120

PREAI

17-α Hydroxyprogesterone Nanoemulsifying Preconcentrate-Loaded Vaginal Tablet: A Novel Non-Invasive Approach for the Prevention of Preterm Birth

17-α 羟孕酮纳米乳化预浓缩阴道片剂: 一种预防早产的新型非侵入性方法

IF5.5

2019-07-1425

OAAI

Immune tolerance attenuates gut dysbiosis, dysregulated uterine gene expression and high-fat diet potentiated preterm birth in mice

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

IF8.4

2019-06-0119

PREAI

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

IF10.1

2019-02-0144

OAAI